...included two hemophilia products being developed by partner Inspiration Biopharmaceuticals Inc. and prostate cancer therapy tasquinimod...
...are going to have to take those risks.” David Meek, Ipsen The second failure was tasquinimod...
...to be highly active between 2011 and the present. But Lebeaut said the hemophilia and tasquinimod...

...treat Crohn's disease and Huntington's disease (HD). Active Biotech and Ipsen Group have TASQ tasquinimod (ABR-215050...

...SSE:ACTI), Lund, Sweden Ipsen Group (Euronext:IPN; Pink:IPSEY), Boulogne-Billancourt, France Product: Tasquinimod ( TASQ ) ( ABR-215050...
...patients with metastatic CRPC who had not received chemotherapy showed that once-daily 0.25-1 mg oral tasquinimod...
...of tasquinimod in patients with prostate cancer after top-line data from the trial showed that tasquinimod...

...37 (66%) to 19 employees after announcing in April that it would discontinue development of tasquinimod...

...Company Setback Active Biotech (SSE:ACTI) / Ipsen Group (Euronext:IPN; Pink:IPSEY) Partners say they will discontinue tasquinimod...
...Pfizer Inc. (NYSE:PFE) CompanySetbackActive Biotech (SSE:ACTI) / Ipsen Group (Euronext:IPN; Pink:IPSEY)Partners say they will discontinue tasquinimod...

...progressed after standard therapies. Ipsen and Active Biotech partnered in 2011 to co-develop and commercialize tasquinimod...
...SSE:ACTI), Lund, Sweden Ipsen Group (Euronext:IPN; Pink:IPSEY), Boulogne-Billancourt, France Product: Tasquinimod ( TASQ ) ( ABR-215050...
...1 mg oral tasquinimod did not improve OS vs. placebo (HR=1.09, 95% CI: 0.94, 1.28). Tasquinimod...

...partner Ipsen Group (Euronext:IPN) said they would discontinue development of tasquinimod to treat prostate cancer. Tasquinimod...
...Phase II trial to treat four other cancer types do not support continued development of tasquinimod...

...trial in patients with advanced cancers that progressed after standard therapies showed that once-daily oral tasquinimod...
...ovarian cancer cohort. In 38 renal cell carcinoma (RCC) patients pretreated with a VEGF inhibitor, tasquinimod...
...SSE:ACTI), Lund, Sweden Ipsen Group (Euronext:IPN; Pink:IPSEY), Boulogne-Billancourt, France Product: Tasquinimod ( TASQ ) ( ABR-215050...

...valsartan Hypertension FDA action 4Q14 Active Biotech AB (SSE:ACTI) / Ipsen Group (Euronext:IPN; Pink:IPSEY) Tasquinimod (TASQ...

...in a hospital setting PDUFA date 7/27/14 Active Biotech AB (SSE:ACTI)/Ipsen Group (Euronext:IPN; Pink:IPSEY) Tasquinimod (TASQ...